SCHEMBL20054434

SCHEMBL20054434

NCc1ncc(-c2ccc(C#Cc3ccc4nc(CN)[nH]c4c3)cc2)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 1/20 0.38
CACNA1H O95180 1/20 0.37
RAD52 P43351 1/20 0.36
UBE2N P61088 1/20 0.36
IDO1 P14902 1/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 2/20 0.36
AAK1 Q2M2I8 2/20 0.35
MAPT P10636 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MMP9 P14780 1/20 0.35
PKM P14618 2/20 0.35
MEN1 O00255 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PDE10A Q9Y233 3/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20054529 0.86 AAK1 (0.46) CACNA1HRAD52UBE2NIDO1KMT2A
SCHEMBL20054554 0.86 AAK1 (0.46) CACNA1HRAD52UBE2NIDO1KMT2A
SCHEMBL20054511 0.84 CACNA1H (0.49) CACNA1HRAD52UBE2NIDO1KMT2A
SCHEMBL20054430 0.81 AAK1 (0.41) CACNA1HRAD52UBE2NIDO1KMT2A
SCHEMBL19488605 0.79 PDE10A (0.35) SCN10AKMT2APOLBAAK1KDM4E
SCHEMBL20054454 0.74 SCN10A (0.36) SCN10APDE10A
SCHEMBL19488589 0.73 AAK1 (0.36) SCN10AAAK1MAPTKDM4EPDE10A
SCHEMBL20054433 0.72 AAK1 (0.52) CACNA1HRAD52UBE2NIDO1KMT2A
SCHEMBL15116602 0.71 SCN10A (0.40) SCN10AAAK1
SCHEMBL19388443 0.71 SCN10A (0.40) SCN10AAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed